Gene Therapy 2019 Global Market Outlook,Research,Trends and Forecast to 2026

WiseGuyReports.Com Publish a New Market Research Report On –“ Gene Therapy 2019 Global Market Outlook,Research,Trends and Forecast to 2026”.

Pune, India - April 15, 2019 /MarketersMedia/ —

Gene Therapy Industry 2019

Description:-

The global gene therapy market is anticipated to reach USD 4,300 million by 2021. The demand for gene therapy is primarily driven by continuous technological advancements and successful progression of several clinical trials targeting treatments with strong unmet need. Moreover, rising R&D spend on platform technologies by large and emerging biopharmaceutical companies and favorable regulatory environment will accelerate the clinical development and the commercial approval of gene therapies in the foreseeable future. Despite promise, the high cost of gene therapy represents a significant challenge for commercial adoption in the forecast period.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3695595-the-future-of-global-gene-therapy-market-to

For more information or any query mail at sales@wiseguyreports.com

Gene therapy involves inactivating a mutated gene that is not functioning properly and introducing a new gene to assist in fighting a disease. Overall, the field of gene therapy continues to mature and advance with many products in development and nearing commercialization. For instance, Spark Therapeutics received approval of Luxturna, a rare form inherited blindness in December 2017. Gene therapy market in late 2017 also witnessed the approvals of Gilead/Kite Pharma’s Yescarta and Novartis’ Kymriah in the cancer therapeutic area.

Gene therapy offers promise in the treatment of range of indications in cancer and genetic disorders. Large Pharmaceuticals and Biotechnology companies’ exhibit strong interest in this field and key among them include Allergan, Shire, Biomarin, Pfizer and GSK. The gene therapy space is witnessing a wave of partnerships and alliances. Pfizer has recently expanded its presence in gene therapy with the acquisition of Bamboo Therapeutics and Allergan entered the field, with the acquisition of RetroSense and its Phase I/II optogenetic program.

North America holds a dominating position in the global gene therapy market which is followed by Europe and the Asia Pacific. The U.S. has maximum number of clinical trials ongoing followed by Europe. Moreover, the field of gene therapy in the U.S. and Europe continues to gain investor attention driven by success of high visible clinical programs and the potential of gene therapy to address strong unmet need with meaningful commercial opportunity. Moreover, the increasing partnerships and alliances and the disruptive potential of gene therapy bodes well for the sector through the forecast period.
Key Findings from the study suggest products accessible in the market are much competitive and manufacturers are progressively concentrating on advancements to pick up an aggressive edge. Companies are in a stage of development of new items in order to guarantee simple implementation and connection with the current gene. The hospatility segment is anticipated to grow at a high growth rate over the forecast period with the expanding utilization of smart locks inferable from expanding security-related worries among clients amid their stay at the hotels. North America is presumed to dominate the global smart locks market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3695595-the-future-of-global-gene-therapy-market-to

Table Of Contents – Major Key Points

1. Gene Therapy Overview
1.1. History and Evolution of Gene Therapies
1.2. What is Gene Therapy
1.3. Types of Gene Therapy
1.4. Ex vivo and in vivo Approaches of Gene Therapy
1.5. RNAi Therapeutics
1.6. CAR-T Technology based Gene Therapy
1.7. Types of Vectors used for Gene Therapy
1.7.1. Viral
1.7.2. Non-Viral

2. Historical Marketed Gene Therapies [2003-2012]
2.1. Rexin-G (Epeius Biotechnologies Corporation)
2.2. Gendicine (SiBiono GeneTech Co., Ltd)
2.3. Neovasculgen [Human Stem Cells Institute (HSCI))
2.4. Glybera (UniQure Biopharma B.V.)

3. First Countries to get an access to Gene Therapies
3.1. Philippines for Rexin-G [2003]
3.2. China for Gendicine [2003]
3.3. Russia for Neovasculgen [2011]
3.4. Selected European Countries for Glybera [2012]

4. Marketed Gene Therapies [Approved in Recent Years]
4.1. KYMRIAH (tisagenlecleucel)
4.1.1. Therapy Description
4.1.2. Therapy Profile
4.1.2.1. Company
4.1.2.2. Approval Date
4.1.2.3. Mechanism of Action
4.1.2.4. Researched Indication
4.1.2.5. Vector Used
4.1.2.6. Vector Type
4.1.2.7. Technology
4.1.2.8. Others Development Activities
4.1.3. KYMRIAH Revenue Forecasted till 2021
4.2. YESCARTA (axicabtagene ciloleucel)
4.2.1. Therapy Description
4.2.2. Therapy Profile
4.2.2.1. Company
4.2.2.2. Approval Date
4.2.2.3. Mechanism of Action
4.2.2.4. Researched Indication
4.2.2.5. Vector Used
4.2.2.6. Vector Type
4.2.2.7. Technology
4.2.2.8. Others Development Activities
4.2.3. YESCARTA Revenue Forecasted till 2021
4.3. LUXTURNA (voretigene neparvovec-rzyl)
4.3.1. Therapy Description
4.3.2. Therapy Profile
4.3.2.1. Company
4.3.2.2. Approval Date
4.3.2.3. Mechanism of Action
4.3.2.4. Researched Indication
4.3.2.5. Vector Used
4.3.2.6. Vector Type
4.3.2.7. Technology
4.3.2.8. Others Development Activities
4.3.3. LUXTURNA Revenue Forecasted till 2021
4.4. STRIMVELIS
4.4.1. Therapy Description
4.4.2. Therapy Profile
4.4.2.1. Company
4.4.2.2. Approval Date
4.4.2.3. Mechanism of Action
4.4.2.4. Researched Indication
4.4.2.5. Vector Used
4.4.2.6. Vector Type
4.4.2.7. Technology
4.4.2.8. Others Development Activities
4.4.3. STRIMVELIS Revenue Forecasted till 2021

5. Comparison of current Regulatory Status for Gene Therapy Products
5.1. U.S
5.2. Europe
5.3. Japan

6. Emerging Gene Therapies [Phase III]
6.1. Gene Based Therapeutics under Development
6.2. Therapy Description

7. Indication of Focus in Gene Therapy
7.1. Cancer
7.2. Neurodegenerative Disorders
7.3. Lysosomal Storage Disorders (LSDs)
7.4. Ocular Diseases
7.5. Muscle Disorders
7.6. Anemia
7.7. Hemophilia
7.8. Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency

Continued……

Buy 1-user PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3695595

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultant Pvt Ltd.
Address: Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com

Source URL: https://marketersmedia.com/gene-therapy-2019-global-market-outlookresearchtrends-and-forecast-to-2026/502768

Source: MarketersMedia

Release ID: 502768

Latest News

How do you teach kids about texting? Bring in the teenagers

Jun 18, 2019

ESSEN, Germany — How do you teach tech-savvy kids to safely navigate the digital world? In Germany, you bring in the teenagers. On a recent day, 18-year-old Chantal Hueben stood in front of a group of fifth-graders and asked them to brainstorm about the messaging program Whatsapp, which most are using to participate in a group chat for their class. They spoke about themes like cyberbullying and what material is OK to post. "Many are not really aware yet of the impact their messages can have on others," says Hueben, dressed all in black except for white sneakers. "We're teaching...

Apple previews new software as it diversifies beyond iPhones

Jun 18, 2019

SAN JOSE, Calif. — Apple, beset by falling iPhone sales, announced upcoming changes to its phone and computer software intended to highlight its new digital services and to further position it as a defender of personal privacy. The revisions previewed Monday during a conference in San Jose, California, included a new feature that will let people log into apps and other services with an Apple ID instead of relying on similar sign-in options from Facebook and Google — two companies that mine data to sell advertising. Apple said it won't collect tracking information about users from that service. As part...

Virtual reality helps police learn to interact with autistic

Jun 18, 2019

WASHINGTON — An autistic man walks out of a store without paying for a toy he picked up. He's followed by a storekeeper demanding he come back inside. The situation quickly escalates, and police are called. Officers arrive, their patrol car's lights flashing and sirens blaring, to find the man in the parking lot, yelling and not responding to their commands. They have a choice: confront the man and risk having the situation turn violent or regroup to figure out a different approach. The scenario is part of a virtual reality simulation for police that's being developed by Axon —...

Anti-groping smartphone app highly popular in Japan

Jun 18, 2019

TOKYO — A smartphone app developed by Japanese police is being widely downloaded by women trying to protect themselves from gropers on packed rush-hour trains. The "Digi Police" app was originally issued by Tokyo police three years ago, but a function to scare off molesters was only added a few months ago. Since then, the app has reportedly been downloaded hundreds of thousands of times — unusual for a government-developed mobile application. Women in crowded trains and other public places in Japan often face sexual harassment, but are typically too afraid to call out for help. With the app, victims...

Nonprofits turn to cryptocurrency to help needy Venezuelans

Jun 18, 2019

BARQUISIMETO, Venezuela — Andreina Cordero started the year skipping meals so her three kids could eat. Her husband, a construction worker, was out of a job. And the family's savings had been devastated by the nation's hyperinflation, limiting Cordero's children to a diet of rice, beans, pasta and fried corn patties. But the family got a break from their daily struggle to feed themselves this spring when a social worker enrolled them in a program run by a Silicon Valley startup that is donating cryptocurrency to hundreds of Venezuelan families. Every week from February to April, Cordero received a deposit...

About Us

Science Thread delivers quality and fascinating science and technology content that matters on a daily basis and makes it go viral.

Contact us: sales@sciencethread.com